Retinoblastoma: An Overview and Latest Advances

Retinoblastoma is the most common paediatric intraocular malignancy, accounting for around 3% of all childhood cancers. Due to their aggressive and potentially life-threatening nature, early diagnosis and treatment are essential. Recent advances in genetic testing, imaging, and targeted therapies have significantly improved outcomes in those affected by retinoblastoma. This article explores the latest advancements in the diagnosis and management of this potentially life-threatening disease.